论文信息 - Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer. - 字舞流文

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.

P. Ellis | T. Welte | M. Ranson | K. O'Byrne | R. Ramlau | R. Pirker | A. Szczesna | R. Rosell | M. Reck | B. Mennecier | G. Robinet | M. Pérol | M. Constenla | A. Chemaissani | R. Kolb | A. Szczęsna | K. Pilz | W. Pfeifer